Turk J Hematol. 2024; 41(1): 61-63 | DOI: 10.4274/tjh.galenos.2024.2023.0477

Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report

Yu-han Gao, Ming-hui Duan, Jian Li, Lu Zhang
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China

Keywords: Idiopathic multicentric Castleman disease, Janus kinase inhibitor, Ruxolitinib, Treatment

---

Refrakter İdiyopatik Multisentrik Castleman Hastalığının Tedavisinde Ruxolitinib: Bir Olgu Sunumu

Yu-han Gao, Ming-hui Duan, Jian Li, Lu Zhang
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China

Anahtar Kelimeler: İdiyopatik multisentrik Castleman hastalığı, Janus kinaz inhibitörü, Ruxolitinib, Tedavi

---

CITE